INTERNATIONAL PATENT: BIONTECH SE FILES APPLICATION FOR "COMBINATION THERAPY COMPRISING THERAPEUTIC RNA CANCER VACCINES AND ANTI-CTLA4 ANTIBODIES FOR CANCER TREATMENT"

GENEVA, Oct. 4 -- BIONTECH SE (An der Goldgrube 1255131 Mainz) filed a patent application (PCT/EP2024/058693) for "COMBINATION THERAPY COMPRISING THERAPEUTIC RNA CANCER VACCINES AND ANTI-CTLA4 ANTIBODIES FOR CANCER TREATMENT" on Mar 28, 2024. With publication no. WO/2025/201659, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SAHIN, Ugur (c/o BioNTech SEAn der Goldgrube 1255131 Mainz), KRANZ, Lena (c/o BioNTech SEAn der Goldgrube 1255131 Mainz), VORMEHR, Mathias (c/o BioNTech SEAn der Goldgrube 1255131 Mainz)

Abstract: T...